Table 2 Clinical outcomes at month 6: patients in remission at month 12 but not month 6

DAS28

6.31 (1.01)

3.17 (1.03) (2.82, 3.52)

5.91 (1.10)

3.22 (1.16) (2.64, 3.79)

6.42 (0.97)

3.17 (1.02) (2.83, 3.51)

6.00 (1.07)

3.34 (1.11) (2.86, 3.82)

SDAI

48.73 (16.05)

11.57 (11.29) (7.75, 15.39)

43.71 (14.77)

11.89 (11.81) (6.02, 17.76)

49.67 (15.68)

11.31 (11.22) (7.57, 15.05)

44.58 (14.58)

12.20 (11.03) (7.42, 16.97)

CDAI

45.68 (14.86)

11.07 (11.18) (7.29, 14.85)

41.17 (14.69)

10.79 (11.34) (5.15, 16.43)

46.44 (14.57)

10.76 (11.12) (7.05, 14.47)

41.69 (13.91)

11.05 (10.65) (6.44, 15.65)

TJC28

17.28 (7.23)

4.17 (5.23) (2.40, 5.94)

15.11 (7.41)

4.06 (5.63) (1.26, 6.86)

17.43 (7.37)

3.97 (5.19) (2.24, 5.70)

15.52 (7.29)

4.26 (5.27) (1.98, 6.54)

SJC28

15.25 (6.15)

3.64 (5.16) (1.89, 5.38)

14.11 (5.71)

3.33 (4.98) (0.86, 5.81)

15.38 (6.09)

3.57 (5.10) (1.87, 5.27)

14.35 (5.42)

3.30 (4.68) (1.28, 5.33)

PGA (0–10 cm VAS)

6.57 (2.47)

2.20 (1.48) (1.70, 2.70)

5.66 (2.87)

1.77 (1.25) (1.14, 2.39)

6.92 (2.29)

2.24 (1.50) (1.74, 2.74)

5.67 (2.82)

1.88 (1.30) (1.32, 2.44)

EGA (0–10 cm VAS)

6.59 (2.02)

1.07 (1.09) (0.70, 1.43)

6.28 (2.12)

1.63 (1.22) (1.03, 2.24)

6.71 (1.87)

0.98 (1.07) (0.62, 1.33)

6.15 (1.95)

1.60 (1.15) (1.11, 2.10)

CRP (mg/dL)

3.05 (2.92)

0.50 (0.56) (0.31, 0.69)

2.54 (2.45)

1.10 (1.38) (0.42, 1.78)

3.24 (2.70)

0.56 (0.58) (0.36, 0.75)

2.89 (2.92)

1.15 (1.24) (0.61, 1.68)

ESR (mm/hour)*

47.93 (23.18)

22.60 (15.36) (14.09, 31.11)

39.11 (27.51)

19.22 (16.42) (6.60, 31.85)

49.06 (26.33)

24.94 (20.27) (14.14, 35.74)

46.18 (35.98)

26.36 (22.86) (11.00, 41.72)